All In MedTech

Device Trial Radar · NCT01528696

Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section

Last checked: Nov 19, 2026Latest source record: Apr 4, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

37

Actual

Start

Feb 2012

Primary completion

Jan 2013

Study completion Jan 2013

Sponsor

Lead sponsor
University of MichiganAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Cura Surgical
First posted
Feb 8, 2012

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Prevention
Who can join
Female only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Obese patients undergoing cesarean section are at high risk for wound complications, which occur in approximately 20% of patients. This is a randomized controlled trial designed to determine whether the risk for wound-related complications can be reduced by covering the incision with a silver-impregnated dressing in the postoperative period.

Conditions

  • Obesity
  • Complications; Caesarean Section, Wound

Interventions

  • SilverlonDevice

    Patients will be randomized to either receive a silver dressing. Patients who receive a silver dressing will have that dressing replaced on postoperative day number 2. This will be left in place until the patient is seen for follow up by the visiting nurse. All patient will be evaluated by the visiting nurse on postoperative day 4 or 5 and have their wounds photographed. All patients will be contacted for a brief survey 6 weeks postpartum.

  • Standard DressingDevice

    Standard island dressing. Patients who receive a standard dressing will have that dressing removed on postoperative day 2. This will be left in place until the patient is seen for follow up by the visiting nurse.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Patients Who Experience One or More Wound ComplicationsTime frame: 6 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Michigan Von Voigtlander Womens' Hospital

    Ann Arbor, Michigan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.